SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001232524-18-000191
Filing Date
2018-11-06
Accepted
2018-11-06 16:09:50
Documents
3
Period of Report
2018-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a3q18form8-k.htm 8-K 26375
2 EXHIBIT 99.1 a3q18financialpr.htm EX-99.1 527844
3 GRAPHIC jazzlogo1a01a01a02a01a05.jpg GRAPHIC 26766
  Complete submission text file 0001232524-18-000191.txt   592224
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 181163064
SIC: 2834 Pharmaceutical Preparations